
Unlocking the Potential of Ycanth: Verrica Pharmaceuticals to Host Virtual KOL Event on the Approval of Cantharidin Topical Solution for Molluscum Treatment on October 11, 2023
Verrica Pharmaceuticals to Host Virtual KOL Event Discussing the Approval of YCANTH™ Exciting News in Dermatology WEST CHESTER, Pa., Sept. 27, 2023 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that it will host a virtual KOL…